Figure 1 Inducers of the NLRP3 inflammasome related

Slides:

Advertisements

Similar presentations

Hal M. Hoffman, MD, Lori Broderick, MD, PhD

Advertisements

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Neutrophils in liver inflammation

The inflammasome in liver disease

Figure 6 Factors modulating SCN5A gene expression

Figure 4 Autophagy and ischaemia–reperfusion

Figure 4 BMI and mortality in patients with heart failure

Nat. Rev. Cardiol. doi: /nrcardio

Figure 5 Two approaches to therapeutic genome editing

Figure 1 Old age, metabolites, and chronic inflammation

Figure 1 Energy supply–demand matching in health and heart failure

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Global rates of sodium, fruit, and vegetable intake

Figure 2 Size categorization of airborne pollutants

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Proactive and reactive prevention of cardiovascular disease

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Molecular mechanisms of crystal-induced necroinflammation

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Innate immune responses in atherosclerosis

Hal M. Hoffman, MD, Lori Broderick, MD, PhD

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Signalling pathways of ischaemic conditioning

Figure 1 Activation and signalling of IL-1

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Cardiovascular risk and disease across the life-course

Figure 6 Proposed arrhythmogenic right ventricular

Transcriptional inflammatory response to hypoxia and cellular necrosis

Nat. Rev. Cardiol. doi: /nrcardio

and obesity-related kidney diseases

Figure 1 Manual thrombus aspiration

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Mechanisms of neutrophil extracellular trap formation

Figure 3 Challenges for big data applications in cardiovascular care

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 3 Effects of cardiovascular medication on the fetus

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 4 Observational studies on multiple treatment strategies

Figure 3 Pathological activation of complement

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Inflammatory health effects of indoor and outdoor particulate matter

Figure 1 Statins, ezetimibe, and PCSK9 inhibitors all increase the expression of LDL receptors and reduce LDL-cholesterol levels (by percentages shown)

Nat. Rev. Cardiol. doi: /nrcardio

Dangerous Liaisons: Mitochondrial DNA Meets the NLRP3 Inflammasome

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Chronic inflammation and DNA damage in people with SLE

Figure 1 NLRP3 inflammasome formation pathways

Nat. Rev. Cardiol. doi: /nrcardio

The mechanisms by which mitochondrial dysfunction in chronic obstructive pulmonary disease (COPD) lead to increased oxidative stress and inflammation,

Therapeutic strategies in inflammasome mediated diseases of the liver

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Initiators of obesity-associated inflammation in adipocytes

Figure 3 Effects of stress

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Volume 84, Issue 6, Pages (December 2013)

The End and After: How Dying Cells Impact the Living Organism

Damage-associated molecular pattern (DAMP)-induced activation of Toll-like receptors (TLRs). Damage-associated molecular pattern (DAMP)-induced activation.

Presentation transcript:

Figure 1 Inducers of the NLRP3 inflammasome related to depression and cardiovascular disease, and inhibitory strategies Figure 1 | Inducers of the NLRP3 inflammasome related to depression and cardiovascular disease, and inhibitory strategies. Several damage-associated molecular patterns (known as DAMPs), such as ATP release, increased levels of cholesterol or glucose, increased levels of IL-1β, reactive oxygen species (ROS), and stress exposure, have been shown to induce NLRP3 inflammasome activation. Given that these potential NLRP3 inflammasome inducers have been associated with the pathophysiology of both depression and cardiovascular diseases, the use of the various NLRP3 inhibitors might be beneficial in both diseases. Alcocer-Gómez, E. & Cordero, M. D. (2017) NLRP3 inflammasome: common nexus between depression and cardiovascular diseases Nat. Rev. Cardiol. doi:10.1038/nrcardio.2016.214